Banco Santander, S.A. Edwards Lifesciences Corp Transaction History

Banco Santander, S.A.

$8.06 Billion
Q2 2024

A detailed history of Banco Santander, S.A. transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Banco Santander, S.A. holds 24,776 shares of EW stock, worth $1.62 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

24,776

Previous 25,515 2.9%

Holding current value

$1.62 Million

Previous $2.44 Million 6.15%

% of portfolio

0.03%

Previous 0.03%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 29, 2024	SELL	$84.3 - $94.31 $62,297 - $69,695	-739 Reduced 2.9%	24,776 $2.29 Million
Q1 2024 May 10, 2024	SELL	$72.54 - $95.56 $5.2 Million - $6.85 Million	-71,729 Reduced 73.76%	25,515 $2.44 Million
Q4 2023 Feb 09, 2024	BUY	$61.71 - $77.76 $117,927 - $148,599	1,911 Added 2.0%	97,244 $7.41 Million
Q3 2023 Nov 08, 2023	BUY	$69.28 - $93.38 $656,843 - $885,335	9,481 Added 11.04%	95,333 $6.6 Million
Q2 2023 Aug 14, 2023	BUY	$81.41 - $94.33 $9,117 - $10,564	112 Added 0.13%	85,852 $8.1 Million
Q1 2023 May 10, 2023	BUY	$74.26 - $84.51 $841,959 - $958,174	11,338 Added 15.24%	85,740 $7.09 Million
Q4 2022 Feb 13, 2023	BUY	$68.3 - $87.44 $313,360 - $401,174	4,588 Added 6.57%	74,402 $5.55 Million
Q2 2022 Jul 28, 2022	BUY	$86.5 - $128.27 $6.04 Million - $8.96 Million	69,814 New	69,814 $6.64 Million
Q4 2021 Feb 09, 2022	SELL	$106.37 - $130.68 $246,672 - $303,046	-2,319 Closed	0 $0
Q3 2021 Nov 08, 2021	BUY	$102.91 - $122.75 $238,648 - $284,657	2,319 New	2,319 $263,000
Q2 2021 Jul 29, 2021	SELL	$83.84 - $104.76 $272,563 - $340,574	-3,251 Closed	0 $0
Q1 2021 May 10, 2021	SELL	$78.68 - $90.67 $196,857 - $226,856	-2,502 Reduced 43.49%	3,251 $272,000
Q4 2020 Feb 12, 2021	SELL	$71.69 - $91.23 $411,142 - $523,204	-5,735 Reduced 49.92%	5,753 $525,000
Q3 2020 Nov 09, 2020	SELL	$67.19 - $87.44 $189,408 - $246,493	-2,819 Reduced 19.7%	11,488 $917,000
Q2 2020 Aug 05, 2020	BUY	$57.54 - $76.95 $583,167 - $779,888	10,135 Added 242.93%	14,307 $989,000
Q1 2020 May 11, 2020	BUY	$52.41 - $81.0 $31,865 - $49,248	608 Added 17.06%	4,172 $787,000
Q4 2019 Feb 07, 2020	BUY	$71.7 - $82.09 $255,538 - $292,568	3,564 New	3,564 $831,000
Q4 2018 Feb 12, 2019	SELL	$46.41 - $56.94 $61,029 - $74,876	-1,315 Closed	0 $0
Q3 2018 Nov 13, 2018	SELL	$45.7 - $58.03 $6.15 Million - $7.81 Million	-134,602 Reduced 99.03%	1,315 $229,000
Q2 2018 Aug 14, 2018	BUY	$42.45 - $51.3 $5.7 Million - $6.89 Million	134,252 Added 8063.18%	135,917 $19.8 Million
Q1 2018 May 14, 2018	SELL	$37.19 - $47.45 $1.99 Million - $2.54 Million	-53,426 Reduced 96.98%	1,665 $232,000
Q4 2017 Feb 14, 2018	BUY	$33.79 - $39.39 $1.32 Million - $1.54 Million	39,091 Added 244.32%	55,091 $6.21 Million
Q2 2017 Aug 11, 2017	BUY	N/A	16,000	16,000 $1.89 Million

Others Institutions Holding EW

# of Institutions

1,417

Shares Held

469M

Call Options Held

2.44M

Put Options Held

2.65M

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $40.5B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Banco Santander, S.A., based on Form 13F filings with the SEC.

News

Stay updated on Banco Santander, S.A. with notifications on news.

Account

Banco Santander, S.A. Edwards Lifesciences Corp Transaction History